← Open Payments lookup

MARY HALLORAN-RUHLE: Open Payments

NPI 1730236142 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,356 in 223 payments from 14 companies in 2025. Trend: 2023 $4,463 · 2024 $4,991 · 2025 $4,356

Food & beverage: $4,356
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc48$872
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)31$705
Alkermes, Inc.19$596
Otsuka America Pharmaceutical, Inc.35$566
E.R. Squibb & Sons, L.L.C.27$448
Teva Pharmaceuticals USA, Inc.25$358
Axsome Therapeutics, Inc.10$232
Neurocrine BioSciences, Inc.11$217
ABBVIE INC.7$157
Vanda Pharmaceuticals Inc.4$65

Products named: CAPLYTA, ARISTADA, INVEGA SUSTENNA, COBENFY, SPRAVATO, REXULTI, AUSTEDO XR, Auvelity.

Industry payments across NY — which companies pay providers there.